Confirmatory Study Nepafenac 0.3%

Inclusion Criteria: * Planned cataract extraction by phacoemulsification with the implantation of a posterior chamber intraocular lens; * Patients who, in the opinion of the Investigator, would have improvement in best-corrected visual acuity after surgery; * Able to understand and sign an informed consent; * Other protocol-defined inclusion criteria may apply. Exclusion Criteria: * Use of topical ocular, inhaled or systemic nonsteroidal anti-inflammatory drugs within 7 days of surgery, with the exception of the allowed low dose of aspirin (up to 100 mg) prior to surgery and through study exit; * Use of topical ocular, inhaled or systemic steroids within 14 days prior to surgery and through study exit; * History of chronic or recurrent inflammatory eye disease (eg, iritis, scleritis, uveitis, iridocyclitis, rubeosis iridis) in the operative eye; * Diabetic retinopathy in the operative eye; * Known or suspected allergy or hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs), or to any component of the test article; * Other protocol-defined exclusion criteria may apply.